Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.6M Buy
+195,000
New +$66.8M 0.3% 77
2026
Q1
Sell
-400,000
Closed -$131M 1019
2025
Q4
$131M Buy
400,000
+200,000
+100% +$63.4M 0.82% 37
2025
Q3
$56.4M Hold
200,000
0.4% 58
2025
Q2
$55.8M Buy
+200,000
New +$56.7M 0.48% 44

Other funds holding AMGN

Marex Group's AMGN Position: Q2 2026 in Review

Marex Group increased its Amgen (AMGN) stake by 8,562% in Q2 2026, buying an estimated $66.9M and bringing the position to 197,671 shares worth $71.6M. The position accounts for 0.3% of the portfolio, ranked #75.

Marex Group first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Marex Group held 197,671 shares of Amgen worth $71.6M as of Q2 2026.
  • Marex Group bought 195,389 Amgen shares in Q2 2026, an estimated $66.9M.
  • Amgen made up 0.3% of Marex Group's portfolio in Q2 2026, its #75 holding.
  • Marex Group first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.